Vertex Pharmaceuticals (VRTX) announced longer-term data for CASGEVY from global clinical trials in people with severe sickle ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Researchers have uncovered a serious side effect of using the CRISPR-Cas gene scissors. A molecule designed to make the process more efficient destroys parts of the genome.
By leveraging the power of CRISPR/Cas9 technology, scientists are working to develop genetically resistant grape varieties, ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced longer-term data for CASGEVYâ„¢ (exagamglogene autotemcel) from global clinical trial ...
Thanks to the revolutionary advancements in CRISPR technology, medical specialists are on the verge of transforming how we ...
Thanks to CRISPR, medical specialists will soon have unprecedented control over how they treat and prevent some of the most ...
The presence of a previously unidentified population of stem cells in sea anemones suggests that these cells may have been ...
CRISPR gene therapy trial for sickle cell disease begins, offering hope for a potential cure by targeting the genetic root of ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...